Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pacira Pharmaceuticals

25.97
-0.7700-2.88%
Post-market: 25.970.00000.00%19:42 EDT
Volume:431.59K
Turnover:11.33M
Market Cap:1.20B
PE:-11.45
High:27.18
Open:26.68
Low:25.95
Close:26.74
Loading ...

Pacira Biosciences Inc - Announces Pcrx-201 Improves Knee Pain for Two Years

THOMSON REUTERS
·
28 Apr

Pacira BioSciences Announces Two-Year Efficacy Data Following a Single Local Administration of PCRX-201 in Patients with Mild to Severe Osteoarthritis of the Knee

GlobeNewswire
·
28 Apr

Pacira BioSciences to Present 104-Week Efficacy Data Following a Single Local Administration of PCRX-201 for Patients with Mild to Severe Osteoarthritis of the Knee

GlobeNewswire
·
23 Apr

BRIEF-DOMA Perpetual Supports Pacira's New $300 Million Share Repurchase Authorization As A Meaningful Step To Enhance Value For Shareholders

Reuters
·
21 Apr

Doma Perpetual Supports Pacira's New $300 Million Share Repurchase Authorization as a Meaningful Step to Enhance Value for Shareholders

THOMSON REUTERS
·
21 Apr

Doma Perpetual - Believes Pacira's Stock Is Undervalued

THOMSON REUTERS
·
21 Apr

DOMA Perpetual Supports Pacira's New $300 Million Share Repurchase Authorization as a Meaningful Step to Enhance Value for Shareholders

PR Newswire
·
21 Apr

Pacira BioSciences Approves $300 Million Share Repurchase Program

MT Newswires Live
·
18 Apr

BRIEF-Pacira Biosciences Inc - Authorizes $300 Million Share Repurchase Program

Reuters
·
18 Apr

Pacira Biosciences Approves $300M Share Buyback

Dow Jones
·
18 Apr

Pacira BioSciences authorizes $300M share repurchase program

TIPRANKS
·
18 Apr

Pacira Biosciences Inc: Reinforces Confidence in 5X30 Plan

THOMSON REUTERS
·
18 Apr

Pacira Biosciences Inc - Authorizes $300 Million Share Repurchase Program

THOMSON REUTERS
·
18 Apr

Pacira BioSciences Reaffirms Commitment to Enhancing Value for All Shareholders

GlobeNewswire
·
18 Apr

Is Pacira BioSciences, Inc. (PCRX) the Best Pharma Stock to Buy for Long Term Growth?

Insider Monkey
·
16 Apr

Pacira Biosciences Reports Inducement Grants Under Nasdaq Listing Rule

Reuters
·
11 Apr

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
11 Apr

Biotech Stock Roundup: PCRX Up on Patent News, EWTX Down on Study Data & More

Zacks
·
10 Apr

Pacira (PCRX) Surges 14.7%: Is This an Indication of Further Gains?

Zacks
·
09 Apr

PCRX Stock Soars on Exparel Patent Settlement With Generic Players

Zacks
·
08 Apr